Echocardiographic effects of dupilumab in patients with severe type 2 asthma
Dupilumab markedly improved cardiac and pulmonary function and may promote clinical remission. Baseline LV-GLS may serve as a predictive marker, supporting cardiovascular assessment in asthma management.
Authors
- Giandomenico Severini (ORCID: https://orcid.org/0009-0003-0136-4594)
- Maria Rosangela Scarcelli
- Alessandro Vatrella (ORCID: https://orcid.org/0000-0001-8265-3037)
- Giovanna Lucia Piazzetta
- Filippo Capilupi
- Chiara Lupia
- Gianluca Ippolito
- Antonio Giacalone
- Carlo Fuoco
- Daniela Pastore
- Emanuela Chiarella
- Alberto Panza
- Girolamo Pelaia
- Angela Sciacqua
- Corrado Pelaia
- Sofia Miceli
Institutions
- University of Salerno (IT)
- Magna Graecia University (IT)
Publication Details
- Journal
- Pulmonary Pharmacology & Therapeutics
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1016/j.pupt.2026.102409
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00